International Journal of Peptide Research and Therapeutics
Scope & Guideline
Fostering Global Collaboration in Peptide Innovation.
Introduction
Aims and Scopes
- Therapeutic Applications of Peptides:
The journal investigates the use of peptides in various therapeutic contexts, including antimicrobial, anticancer, anti-inflammatory, and immunomodulatory applications. This includes the study of naturally occurring peptides, synthetic analogs, and engineered peptide constructs. - Peptide Design and Engineering:
Research published in this journal often focuses on the design, synthesis, and characterization of novel peptides. This includes the use of computational approaches, molecular docking, and structure-activity relationship studies to optimize peptide efficacy and specificity. - Mechanisms of Action:
The journal emphasizes understanding the biochemical and molecular mechanisms through which peptides exert their effects, including studies on signal transduction pathways, receptor interactions, and cellular responses. - Bioinformatics and Computational Modeling:
A significant portion of the research involves computational methods for predicting peptide interactions, designing peptide-based vaccines, and simulating the behavior of peptides in biological systems. - Natural Product Research:
The journal highlights the exploration of peptides derived from natural sources, including plants, animals, and microorganisms, and their potential therapeutic benefits. - Multidisciplinary Approaches to Peptide Research:
Research often integrates various scientific disciplines such as biochemistry, molecular biology, pharmacology, and materials science to advance the field of peptide therapeutics.
Trending and Emerging
- Antimicrobial Peptides (AMPs):
There is a growing body of research focused on the discovery, characterization, and application of antimicrobial peptides as alternatives to conventional antibiotics, particularly in addressing multidrug-resistant pathogens. - Peptide Vaccines:
The development of peptide-based vaccines, particularly in response to emerging infectious diseases such as COVID-19, has gained significant attention, with many studies exploring immunogenicity and efficacy. - Peptides in Cancer Therapy:
Research on peptides that target cancer cells, including their mechanisms of action and potential as therapeutic agents, is rapidly expanding, with a focus on novel delivery systems and combination therapies. - AI and Machine Learning in Peptide Design:
The integration of artificial intelligence and machine learning techniques in peptide design and optimization is emerging as a powerful tool, enhancing the ability to predict peptide interactions and therapeutic potential. - Natural and Synthetic Hybrid Peptides:
There is an increasing interest in hybrid peptides that combine properties of natural and synthetic peptides, aiming to enhance stability and efficacy for therapeutic applications. - Peptides for Neurological Disorders:
Research on the role of peptides in the treatment of neurological conditions, including neurodegenerative diseases and neuroinflammation, is on the rise, highlighting their therapeutic potential in the central nervous system.
Declining or Waning
- Traditional Antibiotics:
There appears to be a waning interest in the development of traditional peptide antibiotics as researchers increasingly focus on innovative approaches, such as multifunctional peptides or peptide-drug conjugates, to combat antibiotic resistance. - Peptides for General Health Supplements:
Research focused on the use of peptides exclusively for general health benefits or as dietary supplements is becoming less prominent, indicating a shift toward more targeted therapeutic applications. - Peptide-Based Diagnostics:
The exploration of peptides specifically for diagnostic applications has decreased, possibly as the field shifts towards integrated approaches that combine diagnostics with therapeutic interventions. - Basic Research in Peptide Chemistry:
While fundamental studies are essential, there is a noticeable decline in publications that focus solely on the basic chemistry of peptides without direct therapeutic implications, reflecting a trend toward more applied research.
Similar Journals
MOLECULAR DIVERSITY
Bridging Disciplines to Inspire Scientific BreakthroughsMOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
Uncovering Hidden Treasures of Asian PharmacologyJOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.
Future Medicinal Chemistry
Advancing the frontiers of drug discovery.Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Elevating Scientific Dialogue in Health ResearchCLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.
European Journal of Medicinal Chemistry Reports
Exploring the frontiers of chemistry and molecular medicine.European Journal of Medicinal Chemistry Reports, published by ELSEVIER, is a vital platform dedicated to advancing the field of medicinal chemistry through open access communication of high-quality research. With an impact factor reflecting its growing influence, this journal has rapidly established a reputation for scholarly excellence since its launch in 2021. It serves as a converging point for innovative studies and reviews that span the disciplines of chemistry and molecular medicine, reflected in its Q2 and Q3 quartile rankings in relevant categories for 2023. Situated in France, the journal is accessible globally, ensuring that researchers, professionals, and students can easily engage with significant findings and methodologies in medicinal chemistry. The open access model facilitates the dissemination of knowledge, bridging gaps between laboratory research and practical applications in drug development. By fostering collaboration and highlighting emerging trends, the European Journal of Medicinal Chemistry Reports plays a crucial role in shaping the future of therapeutic innovations.
JOURNAL OF PEPTIDE SCIENCE
Discovering the intricacies of peptide synthesis and function.JOURNAL OF PEPTIDE SCIENCE, published by Wiley, is a vital resource for researchers and professionals in the fields of biochemistry, drug discovery, and molecular biology. Established in 1995 and encompassing research through 2024, this journal provides a platform for disseminating cutting-edge studies related to peptide synthesis, structure, function, and applications in therapeutics. Although it currently does not offer open access, its robust content has earned it a respectable Q3 ranking in several categories, including biochemistry and pharmacology, according to the latest metrics. Researchers will find significant insights linked to peptide chemistry and its implications in medical sciences, making the JOURNAL OF PEPTIDE SCIENCE an essential addition to academic libraries and for those passionate about peptide research and its potential breakthroughs.
Tissue Engineering and Regenerative Medicine
Connecting Research and Practice in Biomedical InnovationTissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.
Letters in Drug Design & Discovery
Unveiling Novel Approaches in Drug Design & DiscoveryLetters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.
PEPTIDES
Exploring the Frontiers of Peptide BiologyPEPTIDES, published by Elsevier Science Inc, is a premier journal in the field of Biochemistry that has made a significant impact since its inception in 1980. With a current Impact Factor that places it in the Q2 and Q3 quartiles across multiple categories—including Cellular and Molecular Neuroscience and Endocrinology—this journal serves as a vital resource for researchers and professionals seeking to advance their understanding of peptide biology and its broad implications in health and disease. The journal's Scopus ranking reflects its relevance and esteemed contributions, ranking in the top percentiles in various biological disciplines. While currently not available as an open-access option, the depth of peer-reviewed research articles, reviews, and communications offered aims to push the boundaries of knowledge in physiology and molecular biology. As it converges towards 2024, PEPTIDES continues to be a beacon for innovative research that inspires the next generation of scientists.
BIOCHEMICAL PHARMACOLOGY
Innovative research bridging biochemistry and pharmacology.BIOCHEMICAL PHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, stands as a leading international journal devoted to the advancing field of biochemical pharmacology. Since its inception in 1958, the journal has continuously offered a platform for innovative research, delivering critical insights into the interaction between biochemical processes and pharmaceutical applications, and now converges towards its 2024 edition. With an impressive Q1 ranking in both Biochemistry and Pharmacology categories, it ranks 32nd out of 313 in Pharmacology and Toxicology, and 58th out of 438 in Biochemistry according to Scopus, showcasing its significant impact within the scientific community. Researchers and professionals rely on this journal to keep abreast of essential developments, given its robust peer-review process and a comprehensive selection of articles that span experimental studies, clinical trials, and theoretical analyses. Although not an Open Access journal, it remains pivotal for those seeking to advance their knowledge in the dynamic fields of biochemistry and pharmacology. With its high impact factor and emphasis on quality research, BIOCHEMICAL PHARMACOLOGY continues to be an invaluable resource for students, researchers, and industry professionals striving to make breakthroughs in drug development and therapeutic strategies.